Form 8-K - Current report:
SEC Accession No. 0001564590-21-057374
Filing Date
2021-11-17
Accepted
2021-11-17 07:00:23
Documents
12
Period of Report
2021-11-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K stro-8k_20211112.htm   iXBRL 8-K 33959
  Complete submission text file 0001564590-21-057374.txt   162797

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA stro-20211112.xsd EX-101.SCH 5685
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20211112_lab.xml EX-101.LAB 19323
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20211112_pre.xml EX-101.PRE 11483
5 EXTRACTED XBRL INSTANCE DOCUMENT stro-8k_20211112_htm.xml XML 3544
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 211418393
SIC: 2836 Biological Products, (No Diagnostic Substances)